Financings in Brief: Healthdyne Inc.
This article was originally published in The Gray Sheet
Executive Summary
Healthdyne Inc.: Firm's Healthdyne Information Enterprises subsidiary files a registration statement with SEC for a proposed spin-off from its parent company. The filing covers a distribution by Healthdyne Inc. of its "entire interest in its wholly owned clinical information and services subsidiary," proposing that Healthdyne shareholders receive one share of Healthdyne Information Enterprises for each share of Healthdyne. The spin-off would complete Healthdyne's "strategy of separating its operations into independent publicly held companies serving different segments of the healthcare market," the firm says. Following the spin-off, Healthdyne's business would be limited to its home obstetrical care and maternity management services operations. In May, Healthdyne spun off Healthdyne Technologies, its respiratory and obstetrical home care business ("The Gray Sheet" June 5, p. 17)...
You may also be interested in...
New EU Filings
Obecabtagene autoleucel, Autolus Therapeutics’s investigational treatment for relapsed or refractory B cell precursor acute lymphoblastic leukemia, is among the latest products that have been filed for review by the European Medicines Agency for potential EU marketing approval.
Novartis Hires Ex-BMS Chief As It Pursues US Growth Strategy
The Swiss pharma company is looking to tap into the experience of ex-BMS leader Giovanni Caforio to help further it US-first commercial strategy.
Maxwellia Delivers Two UK Menstrual Health Rx-To-OTC Switches
UK switch specialist Maxwellia delivers two “me too” reclassifications in the area of women's health: Evana Heavy Period Relief and Ultravana Period Pain Relief.